Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV

NCT03451032 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03451032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03451032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
March 15, 2018
Completion date
March 15, 2019
Enrollment
150 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hiv